Coherus Biosciences Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$10.2M
Doctors Paid
5,259
Transactions
13,794
2024 Total
$2.2M
Payment Breakdown by Category
Research$7.7M (75.8%)
Consulting$805,950 (7.9%)
Food & Beverage$354,876 (3.5%)
Travel$150,859 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7.7M | 572 | 75.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $925,775 | 300 | 9.1% |
| Consulting Fee | $805,950 | 237 | 7.9% |
| Food and Beverage | $354,876 | 11,973 | 3.5% |
| Honoraria | $239,468 | 125 | 2.3% |
| Travel and Lodging | $150,859 | 587 | 1.5% |
Payments by Type
Research
$7.7M
572 transactions
General
$2.5M
13,222 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| CHS170107 | $1.7M | 0 | 16 |
| CHS14209 | $1.6M | 0 | 4 |
| CHS-131-016 | $1.0M | 0 | 1 |
| SRF114-101 | $787,395 | 0 | 57 |
| A Randomized Phase 2 Trial of Atezolizumab and Bevacizumab in Combination With SRF388 or Placebo in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma | $643,935 | 0 | 188 |
| CHS601 | $533,299 | 0 | 81 |
| A Phase 1/1b Study of CHS-388 (formerly known as SRF388) in Patients with Advanced Solid Tumors | $363,371 | 0 | 206 |
| 305 | $312,095 | 0 | 1 |
| CHS-1701-08 | $286,500 | 0 | 4 |
| CHS-131 | $220,086 | 0 | 1 |
| An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca (POEM) | $207,775 | 0 | 1 |
| CHS-1701-09 | $59,249 | 0 | 12 |
Payments by Medical Specialty
Top Paid Doctors — Page 4
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Saad Munib Ahmed Khan, Md, MD | Hematology | Stanford, CA | $5,893 | $0 |
| Robert Chin, Md, Phd, MD, PHD | Radiation Oncology | Los Angeles, CA | $5,857 | $0 |
| William Velasquez, M. D, M. D | Medical Oncology | Houston, TX | $5,779 | $0 |
| Charles Kuzma, M.d, M.D | Hematology & Oncology | Pinehurst, NC | $5,727 | $0 |
| Dr. Daniel Efiom-Ekaha, Md, MD | Hematology & Oncology | York, PA | $5,637 | $0 |
| Ari Rosenberg, Md, MD | Hematology & Oncology | Chicago, IL | $5,555 | $0 |
| Dr. Bramham Reddy, M.d, M.D | Hematology & Oncology | Lufkin, TX | $5,443 | $0 |
| David Kleinman, Md, MD | Retina Specialist | Rochester, NY | $5,400 | $0 |
| Dr. Judy Kim, Md, MD | Retina Specialist | Dallas, TX | $5,330 | $0 |
| Howard West, Md, MD | Medical Oncology | Duarte, CA | $5,165 | $0 |
| Dr. Mark Socinski, Md, MD | Hematology & Oncology | Orlando, FL | $5,054 | $0 |
| Yiwu Huang, Md, MD | Hematology & Oncology | Brooklyn, NY | $4,964 | $0 |
| Wajahat Khan, Md, MD | Medical Oncology | Grosse Pointe Woods, MI | $4,942 | $0 |
| Simi Masand Rai, Md, MD | Medical Oncology | Allentown, PA | $4,916 | $0 |
| Mr. Ruemu Birhiray, Md, MD | Hematology & Oncology | Indianapolis, IN | $4,880 | $0 |
| Francis Worden, Md, MD | Internal Medicine | Ann Arbor, MI | $4,620 | $0 |
| Dr. Marc Agulnick, Md, MD | Orthopaedic Surgery of the Spine | Mineola, NY | $4,388 | $0 |
| Roger Cohen, Md, MD | Medical Oncology | Philadelphia, PA | $4,284 | $0 |
| Gilberto Lopes, Md, MD | Medical Oncology | Miami, FL | $4,238 | $0 |
| Jaffer Ajani, M.d, M.D | Medical Oncology | Houston, TX | $4,200 | $0 |
| Manish Shah, Md, MD | Medical Oncology | New York, NY | $4,200 | $0 |
| Ranee Mehra, M.d, M.D | Medical Oncology | Baltimore, MD | $4,198 | $0 |
| Unknown Provider | — | — | $4,197 | $0 |
| Dr. Sujatha Hariharan, Md, MD | Hematology & Oncology | Austell, GA | $4,147 | $0 |
| Michael Gibson, M.d. Phd, M.D. PHD | Internal Medicine | Nashville, TN | $4,063 | $0 |
About Coherus Biosciences Inc.
Coherus Biosciences Inc. has made $10.2M in payments to 5,259 healthcare providers, recorded across 13,794 transactions in the CMS Open Payments database. In 2024, the company paid $2.2M. The top product by payment volume is Udenyca ($2.7M).
Payments were distributed across 111 medical specialties. The top specialty by payment amount is Ophthalmology ($461,034 to 691 doctors).
Payment categories include: Food & Beverage ($354,876), Consulting ($805,950), Research ($7.7M), Travel & Lodging ($150,859).
Coherus Biosciences Inc. is associated with 3 products in the CMS Open Payments database.